Jewell Martin serves as the Director for US R&D and Regulatory Policy at BioMarin Pharmaceutical Inc. Prior to joining BioMarin in 2020, Jewell spent 10 years at the US Food and Drug Administration (FDA), where she served in multiple roles including as the Executive Operations Staff Lead in the Office of New Drugs (OND) and as a Project Manager in the Office of Pharmaceutical Quality (OPQ), both in the Center for Drug Evaluation and Research (CDER) and as a biologist at the Center for Veterinary Medicine (CVM) Office of Research (OR). Prior to joining CDER, she worked in clinical trial operations at various institutes at the National Institutes of Health (NIH) for over 5 years.
Jewell received her undergraduate degree and MBA from Howard University in Washington, DC, and a MA in Medical Sciences from Boston University. Additionally, she received certifications including the Project Management Professional (PMP) and a Regulatory Affairs Certification (RAC).
